Hemispherx Biopharma(HEB)

1.80 0.00 0.0%

今开:0.0昨收:1.8
最高:0.0 最低:0.0
涨停价:0.0跌停价:0.0
总市值:4395652.0

Hemispherx Biopharma的热门讨论

Nicole07772015-03-04 19:49

$HEMISPHERX BIOPHARMA INC(HEB)$ Hemispherx upgrades New Jersey Alferon plant months.......[笑]
网页链接查看全文

Nicole07772015-03-03 00:46

$HEMISPHERX BIOPHARMA INC(HEB)$ Recently Healthcare sector stocks are increasing.[想一下]查看全文

Nicole07772015-02-25 04:24

$HEMISPHERX BIOPHARMA INC(HEB)$ Hemispherx Biopharma: Institute of Medicine, the Health Arm of the US National Academy of Sciences Reframes Chronic Fatigue Syndrome (CFS) as a "Systemic Exertion Intolerance Disease" (SEID)By GlobeNewswire, February 23, 2015, 08:30:00 ...查看全文

Nicole07772015-02-15 02:21

$HEMISPHERX BIOPHARMA INC(HEB)$ Hemispherx Biopharma and USAMRIID to Present New Discoveries Concerning the Efficacy of Ampligen(R) Against the Ebola Virus at Upcoming International Symposium on Filoviruses
网页链接查看全文

Nicole07772015-02-15 02:23

$HEMISPHERX BIOPHARMA INC(HEB)$ A great opportunity[复盘]查看全文

网络无间道2015-02-14 00:01

$HEMISPHERX BIOPHARMA INC(HEB)$ 扶不起的“刘阿斗”,走路![哭泣]查看全文

Nicole07772015-02-07 00:17

$HEMISPHERX BIOPHARMA INC(HEB)$ Biotech Stock Mailbag: Hep C stocks, Bluebird, Advaxis, Hemispherx
网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36

Hemispherx Biopharma的最新讨论

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Hemispherx Biopharma的公告

$Hemispherx Biopharma(HEB)$ 8-K - Current report Filed: 2019-08-26 AccNo: 0001493152-19-013386 Size: 83 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 8.01: Oth...

$Hemispherx Biopharma(HEB)$ 8-K - Current report Filed: 2019-08-23 AccNo: 0001493152-19-013294 Size: 62 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接

$Hemispherx Biopharma(HEB)$ DEF 14A - Other definitive proxy statements Filed: 2019-08-20 AccNo: 0001493152-19-013142 Size: 1 MB 网页链接

$Hemispherx Biopharma(HEB)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-14 AccNo: 0001493152-19-012572 Size: 5 MB 网页链接

$Hemispherx Biopharma(HEB)$ 8-K - Current report Filed: 2019-07-22 AccNo: 0001493152-19-010919 Size: 319 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接

$Hemispherx Biopharma(HEB)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-07-22 AccNo: 0001493152-19-010927 Size: 480 KB 网页链接

$Hemispherx Biopharma(HEB)$ SC 13D - General statement of acquisition of beneficial ownership Filed: 2019-06-28 AccNo: 0001493152-19-009885 Size: 54 KB 网页链接

$Hemispherx Biopharma(HEB)$ 8-K - Current report Filed: 2019-06-28 AccNo: 0001493152-19-009853 Size: 73 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Fin...

$Hemispherx Biopharma(HEB)$ 内部交易: 2019-06-27,Exec. 副Chairman/CEO/Pres.,EQUELS THOMAS K. ,买入,2632普通股, $4.37

$Hemispherx Biopharma(HEB)$ 内部交易: 2019-06-21,Director,MITCHELL WILLIAM M ,买入,9677普通股, $4.03

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23